CurrentEndo
Get Weekly

Topic · page 33 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 1,281–1,320 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Res Clin Pract

    Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial

    Cohort study

  2. Diabetes Res Clin Pract

    Impact of Tirzepatide on diet-related quality of life and treatment satisfaction in people with type 2 diabetes mellitus: a retrospective cross-sectional study

    Cross-sectional study

  3. Diabetes Care

    Effectiveness of an Incentives-Enhanced Stepped Care Intervention Program in Diabetes Prevention in a Multiethnic Asian Prediabetes Cohort: Results From the Pre-DICTED Randomized Controlled Trial

    Randomized controlled trial

  4. Diabetes Care

    Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial)

    Secondary analysis

  5. Diabetes Res Clin Pract

    Association of SGLT2 inhibitors and GLP-1 receptor agonists with the risk of Parkinson’s disease in patients with type 2 diabetes: A propensity score–matched cohort study with meta-analysis

    Meta-analysis

  6. Eur J Endocrinol

    Use of skeletal muscle fiber composition to assess relationship between amino acid metabolism and insulin sensitivity

    Cross-sectional study

  7. Diabetes Obes Metab

    Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes

    Cohort study

  8. Diabetes Metab

    Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks

    Cohort study

  9. Diabetes Res Clin Pract

    Glycemic status, early-onset and late-onset dementia, dementia-free lifespan, and brain structure: A population-based cohort study

    Cohort study

  10. Diabetes Obes Metab

    Optimizing cardiovascular health with a type 2 diabetes remission program: Ultraprocessed food‐intake reduction, Mediterranean diet, chrononutrition and physical training—The DIABEPIC ‐2 pilot study

    Research article

  11. Lancet

    Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial

    Randomized controlled trial

  12. Diabetes Obes Metab

    Coated glucose microbeads stimulate enteric hormone release and improve glucose tolerance in Phase 1 and 2 clinical trials

    Randomized controlled trial

  13. Diabetes Obes Metab

    A 7‐year prospective analysis of sustained benefits of multicomponent risk assessment and data‐driven care in patients with type 2 diabetes: The Malaysian JADE Program

    Randomized controlled trial

  14. BMJ Open Diabetes Res Care

    Baseline and longitudinal changes of body roundness index and incident type 2 diabetes: evidence from the UK Biobank cohort

    Cohort study

  15. Diabetes Obes Metab

    Contributions of 2‐h post‐load glucose, fasting blood glucose and glycosylated haemoglobin elevations to the prevalence of diabetes and pre‐diabetes in adults: A systematic analysis of global data

    Meta-analysis

  16. Diabetes Obes Metab

    Dapagliflozin restores odour‐induced functional integration of primary olfactory cortex circuit but not olfactory‐related regional brain activation in patients with type 2 diabetes: A 16‐week randomised comparative study

    Randomized controlled trial

  17. Diabetes Obes Metab

    Efficacy and safety in tirzepatide‐treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS ‐ AP ‐combo and SURPASS ‐3

    Secondary analysis

  18. Obesity (Silver Spring)

    GLP ‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation

    Cohort study

  19. Diabetes Obes Metab

    Joint trajectories of skeletal muscle and fat mass in relation to glucose homeostasis: 6‐Year findings from adults aged ≥50 years

    Cohort study

  20. Diabet Med

    Sulphonylurea efficacy and end‐organ outcomes in the management of HNF4A ‐ MODY

    Cohort study

  21. Clin Endocrinol (Oxf)

    Association Between Serum Uric Acid to Creatinine Ratio and Time in Range in Patients With Type 2 Diabetes

    Cohort study

  22. Diabetes Obes Metab

    Blood glucose trajectories in diabetes patients receiving CAPDCA model of personalised patient education: A cluster randomised controlled trial

    Randomized controlled trial

  23. Lancet Diabetes Endocrinol

    Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial

    Randomized controlled trial

  24. Diabetes Res Clin Pract

    A machine learning algorithm for the prediction of complications incorporated in electronic medical records improves type 2 diabetes care

    Research article

  25. Diabetes Res Clin Pract

    Finnish diabetes risk score (findrisc) for type 2 diabetes screening compared with the oral glucose tolerance test: A systematic review and meta-analysis of diagnostic test accuracy

    Meta-analysis

  26. Endocr Pract

    Inpatient Diet Orders and Continuous Glucose Monitoring in Noncritically Ill, Hospitalized Adult Patients

    Secondary analysis

  27. Diabetes Obes Metab

    Impact of SGLT2 inhibitors on the risk of age‐related ocular diseases in patients with type 2 diabetes mellitus: A target trial emulation study

    Cohort study

  28. Diabetes Obes Metab

    Comparative efficacy and safety of Glucagon‐like pepetide‐1 receptor agonists with metformin in Asian versus non‐Asian patients with type 2 diabetes: A systematic review and meta‐analysis

    Meta-analysis

  29. Endocr Pract

    Comparative Risk of Adverse Pancreatic Events With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP4 Inhibitors, and Sulfonylureas Among Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk

    Cohort study

  30. Pediatr Diabetes

    Increasing Prevalence of Pediatric Type 2 Diabetes in the Republic of Ireland: A National Cross‐Sectional Study

    Cross-sectional study

  31. Diabetes Metab

    Modelled substitution of meat with dairy products and the 20-year cumulative incidence of type 2 diabetes: Insights from the ATTICA cohort study (2002–2022)

    Cohort study

  32. Nat Med

    Association between the English National Health Service Diabetes Prevention Programme and incident multiple long-term conditions

    Cohort study

  33. Diabetes Obes Metab

    The healthcare and economic burden associated with inadequate risk factor control for type 2 diabetes in Hong Kong: A population‐based modelling study

    Cohort study

  34. Diabetologia

    Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council

    Guideline or statement

  35. Diabetes Care

    Quantifying Barriers to Diabetic Eye Screening: A Two-Center Study at the University of California

    Cohort study

  36. Diabetes Res Clin Pract

    The impact of sleep status on lipid profiles and incident type 2 diabetes mellitus: a mediation analysis in a Chinese population cohort

    Cohort study

  37. Diabetes Res Clin Pract

    Comparative effectiveness of OW GLP-1 RAs and other glucose-lowering therapies among Medicare beneficiaries with T2D and ASCVD

    Cohort study

  38. Diabetes Obes Metab

    Cardiovascular risk reduction with glucagon‐like peptide‐1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta‐regression analysis incorporating FLOW and SOUL trials

    Meta-analysis

  39. Lancet Diabetes Endocrinol

    Global, regional, and national cascades of diabetes care, 2000–23: a systematic review and modelling analysis using findings from the Global Burden of Disease Study

    Meta-analysis

  40. Diabetes Obes Metab

    Long‐term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post‐hoc analysis of SURPASS ‐4

    Secondary analysis

All 4,758 Briefs in ExploreShowing Briefs 1,281–1,320 of 4,758, newest first